[Effects of age on causes of hospitalization in children suffering from sickle cell disease]

J R Mabiala-Babela1, S A T Nkanza-Kaluwako, P S Ganga-Zandzou

  • 1Service de pédiatrie-nourrissons, CHU BP. 32, Brazzaville, Congo. j.mabialababela@caramail.com

Insights

Sickle cell disease in children frequently leads to hospitalizations from vaso-occlusive crises, anemia, and infections. Age-specific prevention strategies are crucial for managing complications and improving outcomes in pediatric sickle cell disease patients.

Area of Science:

  • Pediatrics
  • Hematology
  • Public Health

Context:

  • Sickle cell disease (SCD) is a significant global health concern, particularly in pediatric populations.
  • Understanding the epidemiology of SCD complications is vital for effective healthcare planning in endemic regions.
  • This study focuses on SCD in children hospitalized in Brazzaville, Congo, providing regional insights.

Purpose:

  • To determine the frequency and nature of complications in children with sickle cell disease.
  • To analyze the prognosis and mortality rates associated with SCD in pediatric patients.
  • To identify age-specific patterns of SCD manifestations and hospitalizations.

Summary:

  • A retrospective analysis of 251 children with SCD hospitalized between 2002-2003 at Brazzaville Teaching Hospital.
  • Key hospitalization causes included infections (36.6%), vaso-occlusive crises (26.7%), and anemia (20.3%).
  • Mortality was 4.8%, higher in children under five, with anemia crises being a leading cause of death.

Impact:

  • Highlights the significant burden of SCD complications in Congolese children.
  • Underscores the need for age-tailored primary and secondary prevention strategies for pediatric SCD.
  • Informs public health initiatives and clinical management guidelines for SCD in similar settings.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...